Building a global intellectual property moat! Focusfreda's core patented technology has been granted a US invention patent
Recently, the invention patent "Preparation Method for Acetylated Sodium Hyaluronate", applied by Focusfreda， has been officially granted in the United States (Patent No.: US12,435,162B2). This significant achievement marks that the patented technology has successfully established a comprehensive patent protection system covering four major global core markets: China, Japan, Europe, and the United States. The innovative capabilities of Focusfreda in the sodium hyaluronate field have gained authoritative recognition, laying a solid intellectual property foundation for the company's global strategic advancement.
This patented technology is primarily applied in cosmetics and skincare industries. Its core innovation involves converting sodium hyaluronate into acetylated sodium hyaluronate through a unique acetylation reaction. While retaining its original exceptional moisturizing properties, this novel hydrating ingredient optimizes molecular structure by introducing an acetyl group, which enhances both hydrophilic and lipophilic characteristics. This dual enhancement improves skin affinity and adsorption capacity. The resulting formula delivers a refreshing, non-sticky texture with long-lasting hydration, while exhibiting superior skin barrier repair capabilities. It effectively boosts skin elasticity and maintains a smooth, supple complexion.
In the global market competition, the boundaries of intellectual property determine the development territory of enterprises. Looking back at the global licensing journey of this technology, Focusfreda has successively obtained invention patents in China, Japan, Europe, and the United States. This not only signifies international high recognition of the technological innovation but also indicates that the company has established intellectual property barriers covering key global markets in this technical field. This provides a strong guarantee for the smooth entry of enterprise products into international markets and will effectively enhance the initiative and competitiveness of enterprises in international technical cooperation and commercial negotiations.
In the future, Focusfreda will continue to deepen innovation and R&D in sodium hyaluronate and related fields. Taking this global patent portfolio as a new starting point, we will persistently advance technological upgrades and intellectual property protection efforts. With an open mindset for market competition, we aim to deliver more outstanding innovative achievements to serve global clients and inject fresh momentum into industry development!
RECOMMENDED READING
CONTACT US
Tel：+86-0537-3195566
E-mail：sales@focuschem.com
Add：Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China
Copyright © 2022 Shandong Focusfreda Biotech Co., Ltd. 鲁ICP备2021008509号-2 Powerby : 300.cn jinan SEO